Previous Close | 45.98 |
Open | 46.26 |
Bid | 46.13 x N/A |
Ask | 46.42 x N/A |
Day's Range | 45.82 - 46.47 |
52 Week Range | 37.57 - 55.97 |
Volume | |
Avg. Volume | 18,909 |
Market Cap | 1.943B |
Beta (5Y Monthly) | 0.64 |
PE Ratio (TTM) | 26.04 |
EPS (TTM) | 1.78 |
Earnings Date | Aug 07, 2023 - Aug 11, 2023 |
Forward Dividend & Yield | 0.32 (0.70%) |
Ex-Dividend Date | Mar 30, 2023 |
1y Target Est | 56.25 |
Andlauer Healthcare Group Inc. (TSX: AND) ("AHG" or the "Company") announced today the results of voting at its virtual annual meeting of shareholders held on May 4, 2023 (the "Meeting").
Andlauer Healthcare Group Inc. (TSX: AND) ("AHG" or the "Company") today announced the appointment of Mr. Graham Cromb as the Company's Chief Strategy Officer. Mr. Cromb will advance AHG's strategic initiatives and lead the Company's corporate development program.
Andlauer Healthcare Group Inc. (TSX: AND) ("AHG" or the "Company") today reported its financial results for the three-month period ended March 31, 2023 ("Q1 2023").
Andlauer Healthcare Group Inc. (TSX: AND) ("AHG" or the "Company") will release its 2023 first quarter financial results after market close on Wednesday, May 3, 2023. Michael Andlauer, Chief Executive Officer, and Peter Bromley, Chief Financial Officer, will host a conference call for analysts and investors on Thursday, May 4, 2023 at 8:30 a.m. (ET).
Andlauer Healthcare Group Inc. (TSX: AND) ("AHG" or the "Company") today announced that the Toronto Stock Exchange has approved its notice of intention to make a normal course issuer bid for a portion of its subordinate voting shares ("Shares") as appropriate opportunities arise from time to time. AHG's normal course issuer bid (the "NCIB") will be made in accordance with the requirements of the Toronto Stock Exchange.
Andlauer Healthcare Group Inc. (TSX: AND) ("AHG" or the "Company") today announced the Company's first quarter shareholder dividend (encompassing the period from January 1, 2023 to March 31, 2023) in the amount of $0.08 per subordinate voting share and multiple voting share. Payment will be made on April 17, 2023 to shareholders of record as at March 31, 2023.
Andlauer Healthcare Group Inc. (TSX: AND) ("AHG" or the "Company") today reported its financial results for the three-month period ("Q4 2022") and year ended December 31, 2022 ("Fiscal 2022").
Andlauer Healthcare Group Inc. (TSX: AND) ("AHG" or the "Company") will release its 2022 fourth quarter and year-end financial results after market close on Thursday, March 2, 2023. Michael Andlauer, Chief Executive Officer, and Peter Bromley, Chief Financial Officer, will host a conference call for analysts and investors on Friday, March 3, 2023 at 8:30 a.m. (ET).
Andlauer Healthcare Group Inc. (TSX: AND) ("AHG" or the "Company") today announced the Company's fourth quarter shareholder dividend (encompassing the period from October 1, 2022 to December 31, 2022) in the amount of $0.07 per subordinate voting share and multiple voting share. Payment will be made on January 16, 2023 to shareholders of record as at December 30, 2022.
Michael Andlauer, Chief Executive Officer of Andlauer Healthcare Group Inc. (TSX: AND) (the "Company"), announced today that Andlauer Management Group Inc. ("AMG"), a private corporation owned and controlled by Michael Andlauer, has entered into agreements to sell an aggregate of up to 1,760,000 subordinate voting shares in the capital of the Company ("Subordinate Voting Shares"), representing approximately 9.64% of the issued and outstanding Subordinate Voting Shares, for investment purposes. T
Andlauer Healthcare Group Inc. (TSX: AND) ("AHG" or the "Company") today reported its financial results for the three and nine-month periods ended September 30, 2022 ("Q3 2022" and "YTD 2022", respectively).
Andlauer Healthcare Group Inc. (TSX: AND) ("AHG" or the "Company") will release its 2022 third quarter financial results after market close on Tuesday, November 8, 2022. Michael Andlauer, Chief Executive Officer, and Peter Bromley, Chief Financial Officer, will host a conference call for analysts and investors on Wednesday, November 9, 2022 at 8:30 a.m. (ET). The dial-in numbers for participants are (416) 764-8650 or (888) 664-6383. The call will be webcast live at: www.andlauerhealthcare.com/an
Andlauer Healthcare Group Inc. (TSX: AND) ("AHG" or the "Company") today announced the Company's third quarter shareholder dividend (encompassing the period from July 1, 2022 to September 30, 2022) in the amount of $0.07 per subordinate voting share and multiple voting share. Payment will be made on October 17, 2022 to shareholders of record as at September 30, 2022.
Andlauer Healthcare Group Inc. (TSX: AND) ("AHG" or the "Company") today reported its financial results for the three and six-month periods ended June 30, 2022 ("Q2 2022" and "YTD 2022", respectively).
Andlauer Healthcare Group's (TSE:AND) stock up by 6.7% over the past three months. Given its impressive performance, we...
Andlauer Healthcare Group Inc. (TSX: AND) ("AHG" or the "Company") will release its 2022 second quarter financial results after market close on Tuesday, August 9, 2022. Michael Andlauer, Chief Executive Officer, and Peter Bromley, Chief Financial Officer, will host a conference call for analysts and investors on Wednesday, August 10, 2022 at 8:30 a.m. (ET). The dial-in numbers for participants are (416) 764-8650 or (888) 664-6383. The call will be webcast live at: www.andlauerhealthcare.com/pres
Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...
Andlauer Healthcare Group Inc. (TSX: AND) ("AHG" or the "Company") today announced the Company's second quarter shareholder dividend (encompassing the period from April 1, 2022 to June 30, 2022) in the amount of $0.06 per subordinate voting share and multiple voting share. Payment will be made on July 15, 2022 to shareholders of record as at June 30, 2022.
Today we will run through one way of estimating the intrinsic value of Andlauer Healthcare Group Inc. ( TSE:AND ) by...